<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03748043</url>
  </required_header>
  <id_info>
    <org_study_id>171984</org_study_id>
    <nct_id>NCT03748043</nct_id>
  </id_info>
  <brief_title>the Effectiveness of Lactoferrin in Treatment of Iron Deficiency Anemia in Children With Chronic Tonsillitis</brief_title>
  <official_title>the Effectiveness of Lactoferrin in Treatment of Iron Deficiency Anemia in Children With Chronic Tonsillitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>South Valley University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>South Valley University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the investigators will compare the response to iron deficiency anemia to lactoferrin plus
      ferrous poly maltose versus ferrous poly maltose in Children With Chronic Tonsillitis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Iron deficiency is frequently present with chronic inflammatory disease.(1) Iron deficiency
      anemia results from decreased body's iron content due to blood loss, poor dietary iron
      intake, malabsorption, or increased iron requirement. Immune activation drives a diversion of
      iron to storage sites, particularly the mononuclear phagocytes system in liver and spleen
      leads to poor hemoglobinization and anemia. Iron deficiency and immune activation lead to
      disturbances of iron homeostasis.(2) this trial will compare the response to iron deficiency
      anemia to lactoferrin plus ferrous poly maltose versus ferrous poly maltose in Children With
      Chronic Tonsillitis
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 21, 2019</start_date>
  <completion_date type="Anticipated">May 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Increase in blood hemoglobin</measure>
    <time_frame>1,3 months</time_frame>
    <description>mean difference in hemoglobin level between pre treatment and post treatment. mean difference in hemoglobin level between pre treatment and post treatment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Increase in serum ferritin</measure>
    <time_frame>3 months</time_frame>
    <description>mean difference in ferritin level between pre treatment and post treatment.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Iron-deficiency</condition>
  <arm_group>
    <arm_group_label>lactoferrin+ferric hydroxide polymaltose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>lactoferrin 100 mg /day plus ferric hydroxide polymaltose 6 mg /kilogram body wight for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ferric hydroxide polymaltose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6 mg /kilogram body wight of ferric hydroxide poly maltose per day for 3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactoferrin</intervention_name>
    <description>lactoferrin 100 mg per day plus ferric hydroxide polymaltose 6 mg /kilogram of Elemental iron</description>
    <arm_group_label>lactoferrin+ferric hydroxide polymaltose</arm_group_label>
    <other_name>(Pravotin sachets, Hygint, Egypt)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ferric Hydroxide Polymaltose</intervention_name>
    <description>group 2 will receive ferric hydroxide polymaltose 6 mg /kilogram of elemental iron</description>
    <arm_group_label>ferric hydroxide polymaltose</arm_group_label>
    <arm_group_label>lactoferrin+ferric hydroxide polymaltose</arm_group_label>
    <other_name>haemojet syrp</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children 3-17 years old with chronic tonsillitis

        Exclusion Criteria:

          -  no other causes of Iron Deficiency Anemia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>shimaa Ahmed, MD</last_name>
    <role>Study Chair</role>
    <affiliation>South Valley University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>shimaa Ahmed, Lecturer</last_name>
    <phone>+201064920445</phone>
    <email>shimaahaematology@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>South Valley University</name>
      <address>
        <city>QinƒÅ</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>shimaa Ahmed, lecturer</last_name>
      <email>shimaahaematology@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <results_reference>
    <citation>Cappellini MD, Comin-Colet J, de Francisco A, Dignass A, Doehner W, Lam CS, Macdougall IC, Rogler G, Camaschella C, Kadir R, Kassebaum NJ, Spahn DR, Taher AT, Musallam KM; IRON CORE Group. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. Am J Hematol. 2017 Oct;92(10):1068-1078. doi: 10.1002/ajh.24820. Epub 2017 Jul 7. Review.</citation>
    <PMID>28612425</PMID>
  </results_reference>
  <results_reference>
    <citation>Nairz M, Theurl I, Wolf D, Weiss G. Iron deficiency or anemia of inflammation? : Differential diagnosis and mechanisms of anemia of inflammation. Wien Med Wochenschr. 2016 Oct;166(13-14):411-423. Epub 2016 Aug 24. Review.</citation>
    <PMID>27557596</PMID>
  </results_reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>November 18, 2018</study_first_submitted>
  <study_first_submitted_qc>November 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2018</study_first_posted>
  <last_update_submitted>March 17, 2019</last_update_submitted>
  <last_update_submitted_qc>March 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>South Valley University</investigator_affiliation>
    <investigator_full_name>Shimaa Abdallah Ahmed</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tonsillitis</mesh_term>
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lactoferrin</mesh_term>
    <mesh_term>Teferrol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

